Related Experiment Videos

[Castleman's disease]

Terapevticheskii Arkhiv
|August 25, 2005
PubMed

Insights

Castleman's disease (CD) management was studied in 12 HIV-negative patients. Plasmocell CD is difficult to diagnose and lacks treatment, while the hyalinovascular variant shows good surgical outcomes.

Area of Science:

  • Oncology
  • Hematology
  • Pathology

Background:

  • Castleman's disease (CD) is a rare lymphoproliferative disorder with diverse clinical presentations.
  • Understanding the distinct subtypes of CD is crucial for effective management and prognosis.

Purpose of the Study:

  • To present original clinical experience in managing Castleman's disease (CD).
  • To review existing literature data on CD management.
  • To characterize histological and immunophenotypical features of different CD variants.

Main Methods:

  • Retrospective analysis of 12 HIV-negative patients diagnosed with CD.
  • Detailed histological and immunophenotypical characterization of CD subtypes.
  • Review of literature data for comparative analysis.

Main Results:

  • The study included 12 patients (age 18-51 years) with HIV-negative CD.
  • CD subtypes observed were plasmocell (6 patients), mixed (2 patients), and hyalinovascular (4 patients).
  • Three patients with plasmocell CD died from severe autoimmune anemia; patients with hyalinovascular CD achieved remission after surgical node removal.

Conclusions:

  • Diagnosis of plasmocell CD requires exclusion of infections, autoimmune diseases, and lymphomas.
  • Currently, no established therapy exists for the plasmocell variant of CD.
  • Surgical management is effective for the hyalinovascular variant of CD.
Abstract

Related Concept Videos

Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...